Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen.

Autor: Mata-Marín JA; Infectious Diseases Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico., Juárez-Contreras CA; Infectious Diseases Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico., Rodríguez-Evaristo MS; Internal Medicine Department, Hospital de Especialidades, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.; Departamento de Posgrados, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 07360, Mexico., Martínez-Carrizales OC; Psychiatric Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico., Pompa-Mera E; Research Unit, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico., Chaparro Sánchez A; Infectious Diseases Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico., Triana-González S; Infectious Diseases Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico., Cano-Díaz AL; Infectious Diseases Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico., Gaytán-Martínez JE; Infectious Diseases Department, Hospital de Infectología, 'La Raza' National Medical Center, Instituto Mexicano del Seguro Social, Mexico City 02990, Mexico.

Publikováno v: Viruses [Viruses] 2024 Jul 05; Vol. 16 (7). Date of Electronic Publication: 2024 Jul 05.